FDA Adverse Event Injury Summary report: N

COMP RVRS 25MM BSPLT HA+ADPTR

MDR report key: 10185698 · Received June 23, 2020

Report

Report Number
0001825034-2020-02466
Event Type
Injury
Date Received
June 23, 2020
Date of Event
January 7, 2020
Report Date
July 1, 2020
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWS
PMA / PMN Number
K120121
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. THE FOLLOWING SECTIONS WERE UPDATED: B4, B5, G4, G7, H1, H2, H3, H6, H10. DEVICE HISTORY RECORD WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Additional Manufacturer Narrative · 1

(B)(4). FOREIGN REPORT SOURCE: (B)(6). CONCOMITANT MEDICAL PRODUCTS: COMP RVSR SHLDR GLNSP +3 36 MM, CAT: 115313, LOT: 792460. E-POLY 49-36 STD HMRL BRNG, CAT: EP-115373, LOT: 787080. E1 44-36 STD +3 HMRL BRG, CAT: EP-115394, LOT: 345450. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS REVISED APPROXIMATELY 8 MONTHS POST-IMPLANTATION DUE TO INFECTION. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
650751 COMP RVRS 25MM BSPLT HA+ADPTR SHOULDER, PROSTHESIS KWS ZIMMER BIOMET, INC. 370190

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R SEE H10.